Recent News (2)

Envoy Medical Receives Positive Listing Determination from NASDAQ

Oct 27, 2025 8:31:15 AM

White Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2025) - Envoy Medical, Inc. (NASDAQ: COCH)...

Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Oct 7, 2025 8:47:56 AM

The Company expects to complete full enrollment by early 2026 and is moving its timelines up three t...

Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 25, 2025 9:42:06 AM

White Bear Lake, Minnesota--(Newsfile Corp. - September 25, 2025) - Envoy Medical® Inc. (NASDAQ: COC...

Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track

Sep 24, 2025 9:03:19 AM

The Company Begins Strategic Preparations To Support Anticipated Demand And Optimization Of The Accl...

Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 22, 2025 8:45:24 AM

White Bear Lake, Minnesota--(Newsfile Corp. - September 22, 2025) - Envoy Medical® Inc. (NASDAQ: COC...

Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology

Sep 19, 2025 8:32:25 AM

Patent covers advanced signal processing for middle ear sensors, further advancing the Company's pos...

Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments

Sep 10, 2025 9:16:45 AM

Highlights include Expanded Global Patent Portfolio, Complete Debt Elimination Strengthening Balance...

Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology

Sep 9, 2025 9:50:17 AM

Patents strengthen Envoy Medical's innovation pipeline and protect next-generation cochlear implant ...

Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant

Sep 3, 2025 8:37:10 AM

No Serious Adverse Events or Unanticipated Device Effects Reported; Company Confirms Program Remains...

Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board

Aug 26, 2025 9:15:59 AM

Extinguishment simplifies capital structure, strengthens foundation for growth, and eliminates all t...

*The materials and resources presented are intended to be an educational resource for general purposes only. They are not intended to constitute medical or business advice or in any way replace the independent medical judgment of a trained and licensed physician. Each person’s situation is unique and risks, outcomes, experience and results may vary. CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by federal (or United States) law to investigational use.

**See Important Information here.

News Room